A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

Abroad (travel likely)Recruiting

Conditions

Heart Failure With Preserved Ejection Fraction · Coronary Microvascular Dysfunction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Diana Albers) · albers.diana2@mayo.edu · 507-255-6884
Contact: Principal Investigator (Claire Raphael, M.B.B.S., Ph.D.)

Study leads

Claire Raphael, M.B.B.S., Ph.D.
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC)

Heart Failure With Preserved Ejection Fraction

Abroad (travel likely)RecruitingPHASE2

Boston, United States

Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction

Heart Failure With Preserved Ejection Fraction

Abroad (travel likely)Recruiting

Winston-Salem, United States

ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

Aortic Valve Stenosis · Heart Failure

Abroad (travel likely)RecruitingPHASE4

Bucheon-si, South Korea · Changwon, South Korea

Sarcopenia in Older Patients Hospitalized for Acute Heart Failure.

Acute Heart Failure (AHF) · Sarcopenia · Heart Failure

Abroad (travel likely)Recruiting

Madrid, Spain